ABBOTT DIAGNOSTICS TECHNOLOGIES AS: årsregnskap 2024 vs 2023
Grew 44% on revenue, stronger earnings
approved 2025-06-30; registry 2025-08-07; journal 2025 742829
Summary
What changed
Comparing Årsregnskap 2024 with 2023 for ABBOTT DIAGNOSTICS TECHNOLOGIES AS. Revenue 1.38bn NOK → 1.99bn NOK (+43.9%). Net result +62.28m NOK → +382.42m NOK. Equity 1.26bn NOK → 11.82bn NOK.
On the constructive side: revenue rose; operating result improved; net result improved. Pressures included: cash fell.
Also worth watching: paid-in equity reduced; book investments changed; headcount (årsverk) changed. All figures are taken from the published annual accounts for ABBOTT DIAGNOSTICS TECHNOLOGIES AS.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 1.38bn NOK to 1.99bn NOK (+43.9% YoY). Calculated
-
↑
Operating result improved
Operating result -6.50m NOK → +435.38m NOK (op. margin -0.5% → 21.9%). Calculated
-
↑
Net result improved
Net result +62.28m NOK → +382.42m NOK (net margin 4.5% → 19.3%). Calculated
-
↑
Equity strengthened
Book equity 1.26bn NOK → 11.82bn NOK (equity ratio 79.2% → 871.0%). Calculated
What deteriorated
-
↓
Cash fell
Bank deposits 10.86m NOK → 10.15m NOK (-6.6% YoY). Calculated
Things to notice
-
·
Paid-in equity reduced
Paid-in equity fell 1.20bn NOK → 439.89m NOK — check capital reduction, conversion, or reclassification. Interpretation
-
·
Book investments changed
Investment / intangible book value 919.78m NOK → 507.55m NOK. Reported fact
-
·
Headcount (årsverk) changed
Reported FTEs 302 → 302.1. Reported fact